摘要 |
The present invention relates to A compound of formula (I) wherein A, U, V, X, Z, R<1>, Y, R<2 >and R<3 >are defined in the description or a physiologically acceptable salt, solvate or derivative thereof, to compositions and processes for making said compounds and their use in treating conditions ameliorated by an apoB-100 and/or MTP inhibitor.
|